Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 275.70% vs -77.32% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 158.14% vs -2,209.33% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 252.53% vs -464.00% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 205.71% vs -61.11% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Wanbangde Pharmaceutical Holding Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 275.70% vs -77.32% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 20.28% vs -26.94% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 158.14% vs -2,209.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 799.11% vs -55.20% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 252.53% vs -464.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 335.11% vs -36.45% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 205.71% vs -61.11% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 46.58% vs -34.82% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






